Industrial Microbiology, a dynamic branch of microbiology, applies the power of microorganisms to transform industries across diverse sectors. Utilizing bacteria, fungi, and other microbes, it pioneers processes like fermentation, enzyme synthesis, and biofuel creation. This field stands at the forefront of food and beverage production, pharmaceuticals, and environmental stewardship.
In the realm of Industrial Microbiology, microbial alchemy is harnessed for the production of antibiotics, vaccines, and bio-based materials. Within this sphere, microbial biotechnology takes center stage, exploring genetic engineering and bioprocessing techniques for groundbreaking applications. The impact of Industrial Microbiology extends into pharmaceuticals, where it catalyzes the creation of life-saving medications. Moreover, Industrial Microbiologists spearhead advancements in environmental management, deploying microorganisms to break down pollutants in waste treatment processes.
This discipline is a beacon of innovation, constantly propelling eco-friendly solutions and pioneering new frontiers in biotechnology and industrial processes. As Industrial Microbiology continues to evolve, it remains a driving force, revolutionizing industries and shaping a sustainable future.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico